Administrative Core

行政核心

基本信息

  • 批准号:
    10682548
  • 负责人:
  • 金额:
    $ 40.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-30 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary The Minnesota Tissue Mapping Center (MN TMC) for Senescent Cells (SnC) Administrative Core (AC) will be led by two PIs with synergistic expertise: Dr. Laura Niedernhofer, an expert in cellular senescence who participated in the numerous NIH Think Tanks that led to this Common Fund U54 RFA, and Dr. Constantin Aliferis, Director of the UMN Institute for Health Informatics (IHI) and Chief Research Informatics Officer. The main goals of the AC are to facilitate the interaction of all of the MN TMC cores to maximize the TMCs productivity and to create a seamless interface between the MN TMC and other TMCs, the Consortium Organization and Data Coordinating Center (CODCC), and the technology grant (UG3/UH3) awardees to maximize the synergy and productivity of the SenNet Consortium. The specific responsibilities of the AC are to: i) coordinate and provide oversight for the activities of the MN TMC Cores to facilitate access to human tissues, subject clinical data, tissue analysis, data analysis, and data integration; ii) administer a pilot project program focused on developing innovative approaches to identify and characterize SnCs; iii) coordinate MN TMC activities with those of the other TMCs, including working with our Data Analysis Core (DAC) and the CODCC to create standard operating procedures (SOPs) for data management and dissemination; and iv) work with the DAC to ensure delivery of the data generated by our TMC to the CODCC in a timely fashion and in compliance with the SenNet standard operating procedures and Common Data Elements set by the SenNet Steering Committee. The goals of the AC will be achieved through the following aims: 1) Oversee and coordinate efforts of the MN TMC to ensure that research goals and milestones are met with highest quality standards; 2) Integrate input from the MN TMC DAC and the SenNet CODCC to develop and ensure compliance with SOPs for generating data sets that enable the development of a multi-dimensional atlas of SnCs with healthy human aging. 3) Oversee and coordinate the exploration and evaluation of novel approaches for detecting, deeply phenotyping, tracing, and selectively eliminating senescent cells as technologies emerge from pilot projects, Technology Development Projects (UG3/UH3), other TMCs, and other relevant groups studying senescence or building cell atlases; and 4 ) Coordinate the activities of MN TMC with other TMCs to optimize research efficiency and economies of scale and scope, including contributing to the adoption and/or further development of data standards, analytic tools, data sharing/visualization/discovery tools, and multi-site studies and training activities. Successful execution of these aims will optimize the operations of MN TMC, maximize our contribution to SenNet, ensure SOPs that enhance the rigor and reproducibility of the data collected on SnCs, and ensure compliance of our TMC with the Standard Practices established by SenNet.
项目摘要 明尼苏达组织绘图中心(MN TMC)衰老细胞(SnC)管理核心(AC)将在 由两名具有协同专业知识的PI领导:Laura Niedernhofer博士,细胞衰老专家, 我参加了许多NIH智库,导致了这个共同基金U 54 RFA,康斯坦丁博士 阿里弗里斯,UMN健康信息学研究所(IHI)主任和首席研究信息官。的 AC的主要目标是促进所有MN TMC核心的交互,以最大化TMC 为了提高生产力,并在MN TMC和其他TMC之间建立无缝接口, 组织和数据协调中心(CODCC),以及技术赠款(UG 3/UH 3)获奖者, 最大化SenNet Consortium的协同效应和生产力。审核委员会的具体职责如下 (一)协调和监督MN TMC核心的活动,以促进人类获得 组织、受试者临床数据、组织分析、数据分析和数据整合; ii)管理试点项目 该计划侧重于开发创新方法来识别和表征SnCs; iii)协调MN TMC与其他TMC的活动,包括与我们的数据分析核心(DAC)和 CODCC为数据管理和传播制定标准作业程序;以及 与DAC合作,以确保及时将TMC生成的数据交付给CODCC, 遵守SenNet标准操作程序和SenNet设置的通用数据元素 指导委员会。 咨询委员会的目标将通过以下目标实现:1)监督和协调国家网络的工作 TMC确保研究目标和里程碑符合最高质量标准; 2)整合来自 MN TMC DAC和SenNet CODCC制定并确保符合生成数据的SOP 集,使健康的人类衰老的SnCs的多维图谱的发展。3)监督 并协调探索和评估用于检测、深度表型分析、追踪 并选择性地消除衰老细胞作为技术出现从试点项目,技术开发 项目(UG 3/UH 3)、其他TMC和其他研究衰老或构建细胞图谱的相关团体;以及 4 协调MN TMC与其他TMC的活动,以优化研究效率和规模经济 和范围,包括促进采用和/或进一步发展数据标准,分析工具, 数据共享/可视化/发现工具,以及多地点研究和培训活动。成功执行 这些目标将优化MN TMC的运营,最大限度地提高我们对SenNet的贡献, 提高SnC上收集的数据的精确性和可重复性,并确保我们的TMC符合 SenNet制定的标准实践。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura Jane Niedernhofer其他文献

Laura Jane Niedernhofer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura Jane Niedernhofer', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10385162
  • 财政年份:
    2021
  • 资助金额:
    $ 40.88万
  • 项目类别:
Immune cells as a driver of cell non-autonomous aging
免疫细胞是细胞非自主衰老的驱动因素
  • 批准号:
    9765815
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
Immune cells as a driver of cell non-autonomous aging
免疫细胞是细胞非自主衰老的驱动因素
  • 批准号:
    9902309
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
Immune cells as a driver of cell non-autonomous aging
免疫细胞是细胞非自主衰老的驱动因素
  • 批准号:
    10554340
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
Immune cells as a driver of cell non-autonomous aging
免疫细胞是细胞非自主衰老的驱动因素
  • 批准号:
    10343834
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
Role of immunosenescence in Alzheimer's disease
免疫衰老在阿尔茨海默病中的作用
  • 批准号:
    10286343
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
Measuring nucleotide excision repair in human populations
测量人群中的核苷酸切除修复
  • 批准号:
    10202603
  • 财政年份:
    2018
  • 资助金额:
    $ 40.88万
  • 项目类别:
Measuring nucleotide excision repair in human populations
测量人群中的核苷酸切除修复
  • 批准号:
    9789289
  • 财政年份:
    2018
  • 资助金额:
    $ 40.88万
  • 项目类别:
The contribution of DNA interstrand crosslinks to aging
DNA链间交联对衰老的贡献
  • 批准号:
    7916931
  • 财政年份:
    2009
  • 资助金额:
    $ 40.88万
  • 项目类别:
The contribution of DNA interstrand crosslinks to aging
DNA链间交联对衰老的贡献
  • 批准号:
    7494964
  • 财政年份:
    2007
  • 资助金额:
    $ 40.88万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.88万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.88万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了